Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Diabetologia. 2012 Nov 24;56(3):598–607. doi: 10.1007/s00125-012-2782-z

Fig. 5.

Fig. 5

Effect of TUDCA on tunicamycin (TM)-induced PTP1B protein levels in myotubes. Representative western blots (a) and densitometric analysis (mean ± SEM, n=3) of PTP1B (b), GRP78 (c) and phospho- and total eIF2α (p-eIF2α and t-eIF2α, respectively) (d) in C2C12 myotubes treated with tunicamycin in presence of 1 mmol/l TUDCA for 24 h. **p<0.01 compared with non-treated control cells; ††p<0.01 compared with TM-treated cells